• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 4

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Number of scientific manuscripts facilitating development of MCM published in the quarterMEDICAL COUNTERMEASURES INITIATIVEN/AMedical Countermeasures Initiative Strategic Plan 2012 - 2016Establish and sustain a MCM regulatory science program
2Number of external presentations facilitating development of MCM to Advisory Committees, Workshops, Professional Society meetings, etc. in the quarterMEDICAL COUNTERMEASURES INITIATIVEN/AMedical Countermeasures Initiative Strategic Plan 2012 - 2016Establish and sustain a MCM regulatory science program
3Animal Models of Pregnancy to Address Medical Countermeasures (MCM) for Influenza and Chemical, Biological, Radiological and Nuclear Threats in the 'At-Risk' Population of Pregnant WomenMEDICAL COUNTERMEASURES INITIATIVEN/AMedical Countermeasures Initiative Strategic Plan 2012 - 2016Establish and sustain a MCM regulatory science program
4Medical Countermeasure DevicesMEDICAL COUNTERMEASURES INITIATIVEN/AMedical Countermeasures Initiative Strategic Plan 2012 - 2016Modernize the legal, regulatory and policy environment to support preparedness for and response to threats with MCMs

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.